Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released May 6, 2024, after the close
10-Q filed May 6, 2024, 36 days after period end · 0000950170-24-053582
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$25.01M | -$23.95M | -$23.16M | -$16.51M |
| EPS Diluted | -$0.37 | -$0.53 | -$0.59 | -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR